The meeting with something for everyone! Below is a sneak peek at some of the 2015 ACR/ARHP Annual Meeting’s scientific sessions and content specific to each educational track. Basic Science Track Our knowledge of autoimmunity, bone pathology and other aspects of rheumatic disease is expanding rapidly due to the important research data produced by scientists…
Career Corner: Whether you're a new rheumatology fellow, an experienced academic rheumatologist, a researcher or a rheumatologist in private practice, you'll find resources in the articles here designed to help you at every stage of your career. You can find information on academic vs. private practice, how to navigate an employment offer, compensation models, noncompete agreements and even tips for selling your practice.
In addition, be sure to review the ACR's career resources: ACR CareerConnection and FIT Career Roadmap.
ARHP/EULAR Health Professionals Collaboration Update
Over the past few years, the ARHP and the European League Against Rheumatism (EULAR) health professional (HP) leaders have met informally at the EULAR Congress and the ACR/ARHP Annual Meeting to identify a mutually beneficial project to be pursued. At the 2013 EULAR Congress, ARHP and EULAR leaders agreed to formally organize a meeting of…
2015 ACR/ARHP Annual Meeting to Offer Clinical Focus Course
Want to hear about the latest advances in rheumatoid arthritis (RA), osteoarthritis (OA), systemic lupus erythematosus (SLE) and polymyositis/dermatomyositis and how best to implement interprofessional care for your patients? The Association of Rheumatology Health Professionals (ARHP) Clinical Focus Course (CFC) is the course for you. The CFC is a full-day course titled, Clinical Advances in…
ACR Issues Physician-Driven Position Statement on ABIM’s Maintenance of Certification Requirements
ATLANTA—The American College of Rheumatology has released a statement outlining the ACR’s position on the American Board of Internal Medicine’s (ABIM’s) Maintenance of Certification (MOC) requirements. The position statement was drafted and vetted during a three-month collaboration between ACR leadership and its members where nearly 1,100 rheumatologists provided feedback that was used to formulate the…
2016 ACR/ARHP Annual Meeting: Session & Study Group Proposals Welcome
Turn your great idea into a great meeting! Submit your session or study group proposal for the 2016 ACR/ARHP Annual Meeting, to be held Nov. 11–16, 2016, in Washington, D.C. We are looking for ideas that reflect clinical innovation and cutting-edge research, convey best practices, present evidence-based medicine and stimulate discussion to challenge mindsets. When developing your…
Rheumatology Research Foundation Funds Advance Investigator’s Career
William Robinson, MD, PhD, first became interested in rheumatology in medical school when he started working with a rheumatologist, as well as several other rheumatology mentors. After completing his residency, he joined the rheumatology fellowship program at Stanford University Medical Center, Palo Alto, Calif., where he earned support for his research from the Rheumatology Research…
7 Tips for New Rheumatology Fellows
About a year ago, I stuffed all my earthly belongings into my black Volkswagen Jetta and set out on a 10-hour interstate journey. I had just graduated from residency at the University of Kentucky and was headed westward, to Iowa City, for a fresh start as a rheumatology fellow. During the 10 hours I spent…
Maintaining Board Certification Has High Hidden Cost
NEW YORK (Reuters Health)—The American Board of Internal Medicine (ABIM) maintenance-of-certification (MOC) program could cost $5.7 billion in physicians’ time and fees over the next decade, according to a new model study. “We estimate that physicians will spend 33 million hours over 10 years to fulfill MOC requirements,” Dr. Dhruv S. Kazi from the University…
Rheumatologists on the Move, July 2015
Arthritis Center Renamed to Honor Ephraim P. Engleman, MD Ephraim P. Engleman, MD, has been on the faculty at the University of California, San Francisco (UCSF) since 1947, 10 years after he received his MD from Columbia University. The 104-year-old rheumatologist is currently the director of the Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, which…
The ACR’s State-of-the-Art Clinical Symposium: Experts Discuss Jakinibs, Osteoarthritis, Membranous Lupus Nephritis
CHICAGO—With the approval of the Jak inhibitors (i.e., jakinibs) tofacitinib and ruxolitinib—and others being investigated—rheumatologists need to arm themselves with an understanding of these drugs so they can think critically when evaluating them and deciding how to use them, said John O’Shea, MD, chief of the Molecular Immunology and Inflammation Branch of and scientific director…
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 66
- Next Page »